Skip to main content
2025 Global Regulatory Strategy Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

  1. Home
  2. Full Schedule
*Program and presenters are subject to change. Please check back frequently for updates.

Full Schedule

  • Tuesday, March 11, 2025
  • 8:00 AM – 9:00 AM EST
    Breakfast
  • 8:00 AM – 5:00 PM EST
    Registration
  • 9:00 AM – 10:15 AM EST
    Opening Plenary: AI in Regulatory Science - Past, Present and Future
  • 10:15 AM – 10:45 AM EST
    Coffee and Refreshments Break
  • 10:45 AM – 11:45 AM EST
    AI Governance in Healthcare: A Cross-Jurisdictional Global Analysis of Regulatory Approaches
  • 10:45 AM – 11:45 AM EST
    Strategic Authoring in Clinical Study Reports to Leverage AI for Data Privacy and Public Disclosure
  • 11:55 AM – 12:55 PM EST
    Just How Minimal Can Minimal Manipulation Be to Remain Minimal
  • 11:55 AM – 12:55 PM EST
    Mastering Intended Use for Complex and Emerging Medical Technologies
  • 12:55 PM – 2:25 PM EST
    Lunch.
  • 1:45 PM – 2:15 PM EST
    Table 1: Solutions Circle: AI and Drug Development: Regulatory Perspective
  • 1:45 PM – 2:15 PM EST
    Table 2: Solutions Circle: Applying a Risk-Based Approach to AI: Risk Management for AI in Drug Development, IVDs, and SaMD
  • 1:45 PM – 2:15 PM EST
    Table 3: Solutions Circle: De-risking regulatory strategy with evidence-driven insights from across the global landscape, powered by AI
  • 1:45 PM – 2:15 PM EST
    Table 4: Solutions Circle: Designing Clinical Trials for Complex and Branded Generics - Global Development Challenges and Mitigation Strategy
  • 1:45 PM – 2:15 PM EST
    Table 5: Solutions Circle: Establishing and Maintaining the Right Level of Clinical Evidence Under the EU IVDR
  • 1:45 PM – 2:15 PM EST
    Table 6: Solutions Circle: Finding a Path to Yes: Demonstrating the Value of Regulatory Affairs
  • 1:45 PM – 2:15 PM EST
    Table 7: Solutions Circle: Impending Product Shortages and Potential Changes from the European Commission
  • 1:45 PM – 2:15 PM EST
    Table 8: Solutions Circle: Optimizing Probability of Technical and Regulatory Success Leveraging Precedent Intelligence through Digital and AI
  • 1:45 PM – 2:15 PM EST
    Table 9: Solutions Circle: Strategies to Incorporate Conflicting Notified Body Feedback During MDR Review and Minimize Registration Impact
  • 2:25 PM – 3:25 PM EST
    It’s all in the Label: Leveraging Labels to drive regulatory, clinical and commercial strategy
  • 2:25 PM – 3:25 PM EST
    Structured methods for a robust benefit risk assessment throughout the device lifecycle
  • 3:35 PM – 4:35 PM EST
    Bridging the Gap from Product Development to Pivotal IDE Study Readiness
  • 3:35 PM – 4:35 PM EST
    Diversity in Clinical Trials: An Analysis of FDA Guidances to Inform Best Practices
  • 4:35 PM – 5:50 PM EST
    Coffee and Refreshments Break
  • 4:50 PM – 5:50 PM EST
    Practical and Comparative Analysis of CDS Software Regulations in the US and LATAM
  • 4:50 PM – 5:50 PM EST
    Strategic Considerations for Joint Review Procedures of CTAs – Lessons Learned from EU and Africa
  • 6:00 PM – 7:00 PM EST
    Opening Night Networking Reception